41st treatment shown to reduce risk in
November 2022, now with p = 0.0066 from 3 studies, recognized in 13 countries.
Lower risk for recovery.
No treatment is 100% effective. Protocols
combine treatments.
5,400+ studies for
117 treatments. c19early.org
|
|
recovery time, 31.2% lower, relative time 0.69, p = 0.02, treatment mean 3.33 (±1.91) n=18, control mean 4.84 (±2.19) n=25.
|
|
recovery time, 27.9% lower, relative time 0.72, p = 0.04, treatment mean 5.39 (±2.36) n=18, control mean 7.48 (±3.78) n=25, lung lesion absorption start.
|
|
recovery time, 17.2% lower, relative time 0.83, p = 0.03, treatment mean 14.11 (±4.16) n=18, control mean 17.04 (±4.42) n=25, lung lesion absorption greater than 70%.
|
|
hospitalization time, 8.2% lower, relative time 0.92, p = 0.22, treatment mean 16.56 (±3.71) n=18, control mean 18.04 (±3.97) n=25.
|
|
time to viral-, 29.3% lower, relative time 0.71, p = 0.05, treatment mean 4.72 (±2.16) n=18, control mean 6.68 (±3.76) n=25.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
